NN Investment Partners Holdings’s West Pharmaceutical WST Stock Holding History

NN Investment Partners Holdings’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$7.46M	Buy	18,153 +1,553	+9%	+$608K	0.04%	329
2021 Q4	$7.79M	Buy	+16,600	New	+$7.15M	0.04%	342
2021 Q1	–	Sell	-7,800	Closed	-$2.21M	–	821
2020 Q4	$2.21M	Sell	7,800 -7,000	-47%	-$1.96M	0.01%	504
2020 Q3	$4.07M	Sell	14,800 -43,324	-75%	-$11.5M	0.03%	383
2020 Q2	$13.2M	Buy	58,124 +21,624	+59%	+$4.25M	0.09%	187
2020 Q1	$5.56M	Buy	36,500 +31,700	+660%	+$4.88M	0.05%	297
2019 Q4	$722K	Hold	4,800	–	–	﹤0.01%	625
2019 Q3	$681K	Buy	+4,800	New	+$661K	0.01%	630

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

NN Investment Partners Holdings's WST Position: Q1 2022 in Review

NN Investment Partners Holdings increased its West Pharmaceutical (WST) stake by 9.4% in Q1 2022, buying an estimated $608K and bringing the position to 18,153 shares worth $7.46M. The position accounts for 0.04% of the portfolio, ranked #329.

NN Investment Partners Holdings first reported a position in WST in Q3 2019 and has held it in 8 quarters since. The position peaked at $13.2M in Q2 2020. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.

NN Investment Partners Holdings held 18,153 shares of West Pharmaceutical worth $7.46M as of Q1 2022.
NN Investment Partners Holdings bought 1,553 West Pharmaceutical shares in Q1 2022, an estimated $608K.
West Pharmaceutical made up 0.04% of NN Investment Partners Holdings's portfolio in Q1 2022, its #329 holding.
NN Investment Partners Holdings first reported a position in West Pharmaceutical in Q3 2019 and has held it in 8 quarters since.
NN Investment Partners Holdings's West Pharmaceutical position peaked at $13.2M in Q2 2020.
717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.